Winship Cancer Institute of Emory University at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Winship Cancer Institute of Emory University takes part in 4 sessions at ESMO 2026 in Madrid. Its sessions cover breast cancer, from genomic testing in early disease to treatment after progression on CDK4/6 inhibitors, plus cancer prevention and cell therapy in melanoma. It reports overall survival from the phase 3 postMONARCH trial of abemaciclib with fulvestrant, and recommendations on cancer risk linked to obesity and metabolism.
| Organization | ESMO 2026 Attendance |
|---|---|
Winship Cancer Institute of Emory University Atlanta, GA | |
National Cancer Institute-designated comprehensive cancer centre of Emory University, a private research university in Atlanta, Georgia. | Talk Fri Oct 23 14:30–14:50 Autologous cell therapy: Getting the fit right Melanoma & skin cancers Abstract Sat Oct 24 10:59–11:04 Chair Mon Oct 26 08:30–10:00 Talk Mon Oct 26 08:50–09:10 Talk Mon Oct 26 15:05–15:25 Current use of genomic assays Breast cancer |
Instantly find 20 buyers from Winship Cancer Institute of Emory University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction